SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-003194
Filing Date
2018-01-22
Accepted
2018-01-22 08:46:56
Documents
5
Period of Report
2018-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-3548_18k.htm 8-K 66316
2 EX-2.1 a18-3548_1ex2d1.htm EX-2.1 1046798
3 EX-3.1 a18-3548_1ex3d1.htm EX-3.1 7332
4 EX-10.1 a18-3548_1ex10d1.htm EX-10.1 24085
5 EX-99.1 a18-3548_1ex99d1.htm EX-99.1 62276
  Complete submission text file 0001104659-18-003194.txt   1208056
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 18538869
SIC: 2836 Biological Products, (No Diagnostic Substances)